The Importance of Tumor Length in Needle Biopsies of the Prostate
Abstract Objectives To form a composite predictor variable that combines the effects of tumor length, serum prostate-specific antigen (PSA), and International Society of Urologic Pathologists (ISUP) grade on the observation of adverse prostatectomy pathology. Methods Logistic regression analysis was...
Gespeichert in:
| Veröffentlicht in: | American journal of clinical pathology 2020-10, Vol.154 (4), p.533-535 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 535 |
|---|---|
| container_issue | 4 |
| container_start_page | 533 |
| container_title | American journal of clinical pathology |
| container_volume | 154 |
| creator | Vollmer, Robin T |
| description | Abstract
Objectives
To form a composite predictor variable that combines the effects of tumor length, serum prostate-specific antigen (PSA), and International Society of Urologic Pathologists (ISUP) grade on the observation of adverse prostatectomy pathology.
Methods
Logistic regression analysis was used to demonstrate how tumor length, serum PSA, and ISUP grade related to adverse prostatectomy results and to derive weighting factors for a composite variable, cx.
Results
The composite variable, cx, relates closely to adverse prostatectomy results as well as to observed PSA failure.
Conclusions
The composite variable cx uses preoperative information that may allow the sorting of patients into low, intermediate, and high risk for adverse outcomes after prostatectomy. |
| doi_str_mv | 10.1093/ajcp/aqaa068 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2415286939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A645080202</galeid><oup_id>10.1093/ajcp/aqaa068</oup_id><sourcerecordid>A645080202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-81b59fe102b8286446520f3823235a22dd5e857465d48bc31ad2550aa9f485903</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYMoOj52rqXgQhd25ubVpstRfMGgLsZ1yLS32qFtatIu_PdmmFFRRO7iwuU7h5McQo4pjClkfGKWeTcxb8ZAorbIiGaCx2nK2DYZAQCLM5ryPbLv_RKAMgVil-xxJmVCqRiR6fwVo_ums643bY6RLaP50FgXzbB96V-jqo0eEIsao8vKdr5Cv0L6IHpy1vemx0OyU5ra49FmH5Dnm-v51V08e7y9v5rO4lyypI8VXcisRApsoZhKhEgkg5IrxhmXhrGikKhkGs6FUIucU1OEkGBMVgolM-AH5Hzt2zn7NqDvdVP5HOvatGgHr5mgMhhnPAvo6S90aQfXhnSBSsPDFVfqm3oxNeqqLW3vTL4y1dNESFDAgAVq_AcVpsCmym2LZRXuPwQXa0EePsg7LHXnqsa4d01BrxrTq8b0prGAn2yyDosGiy_4s6IAnK0BO3T_W30Acq-axg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476118388</pqid></control><display><type>article</type><title>The Importance of Tumor Length in Needle Biopsies of the Prostate</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Vollmer, Robin T</creator><creatorcontrib>Vollmer, Robin T</creatorcontrib><description>Abstract
Objectives
To form a composite predictor variable that combines the effects of tumor length, serum prostate-specific antigen (PSA), and International Society of Urologic Pathologists (ISUP) grade on the observation of adverse prostatectomy pathology.
Methods
Logistic regression analysis was used to demonstrate how tumor length, serum PSA, and ISUP grade related to adverse prostatectomy results and to derive weighting factors for a composite variable, cx.
Results
The composite variable, cx, relates closely to adverse prostatectomy results as well as to observed PSA failure.
Conclusions
The composite variable cx uses preoperative information that may allow the sorting of patients into low, intermediate, and high risk for adverse outcomes after prostatectomy.</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1093/ajcp/aqaa068</identifier><identifier>PMID: 32556114</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adult ; Aged ; Biopsy ; Biopsy, Needle ; Cancer surgery ; Care and treatment ; Humans ; Male ; Measurement ; Middle Aged ; Neoplasm Grading ; Pathology ; Physiological aspects ; Prognosis ; Prostate ; Prostate cancer ; Prostate-specific antigen ; Prostate-Specific Antigen - blood ; Prostatectomy ; Prostatic Neoplasms - mortality ; Prostatic Neoplasms - pathology ; Tumors ; Urological surgery</subject><ispartof>American journal of clinical pathology, 2020-10, Vol.154 (4), p.533-535</ispartof><rights>American Society for Clinical Pathology, 2020. 2020</rights><rights>American Society for Clinical Pathology, 2020.</rights><rights>COPYRIGHT 2020 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-81b59fe102b8286446520f3823235a22dd5e857465d48bc31ad2550aa9f485903</citedby><cites>FETCH-LOGICAL-c526t-81b59fe102b8286446520f3823235a22dd5e857465d48bc31ad2550aa9f485903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32556114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vollmer, Robin T</creatorcontrib><title>The Importance of Tumor Length in Needle Biopsies of the Prostate</title><title>American journal of clinical pathology</title><addtitle>Am J Clin Pathol</addtitle><description>Abstract
Objectives
To form a composite predictor variable that combines the effects of tumor length, serum prostate-specific antigen (PSA), and International Society of Urologic Pathologists (ISUP) grade on the observation of adverse prostatectomy pathology.
Methods
Logistic regression analysis was used to demonstrate how tumor length, serum PSA, and ISUP grade related to adverse prostatectomy results and to derive weighting factors for a composite variable, cx.
Results
The composite variable, cx, relates closely to adverse prostatectomy results as well as to observed PSA failure.
Conclusions
The composite variable cx uses preoperative information that may allow the sorting of patients into low, intermediate, and high risk for adverse outcomes after prostatectomy.</description><subject>Adult</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Cancer surgery</subject><subject>Care and treatment</subject><subject>Humans</subject><subject>Male</subject><subject>Measurement</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Pathology</subject><subject>Physiological aspects</subject><subject>Prognosis</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Prostate-specific antigen</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - mortality</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Tumors</subject><subject>Urological surgery</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtLxDAUhYMoOj52rqXgQhd25ubVpstRfMGgLsZ1yLS32qFtatIu_PdmmFFRRO7iwuU7h5McQo4pjClkfGKWeTcxb8ZAorbIiGaCx2nK2DYZAQCLM5ryPbLv_RKAMgVil-xxJmVCqRiR6fwVo_ums643bY6RLaP50FgXzbB96V-jqo0eEIsao8vKdr5Cv0L6IHpy1vemx0OyU5ra49FmH5Dnm-v51V08e7y9v5rO4lyypI8VXcisRApsoZhKhEgkg5IrxhmXhrGikKhkGs6FUIucU1OEkGBMVgolM-AH5Hzt2zn7NqDvdVP5HOvatGgHr5mgMhhnPAvo6S90aQfXhnSBSsPDFVfqm3oxNeqqLW3vTL4y1dNESFDAgAVq_AcVpsCmym2LZRXuPwQXa0EePsg7LHXnqsa4d01BrxrTq8b0prGAn2yyDosGiy_4s6IAnK0BO3T_W30Acq-axg</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Vollmer, Robin T</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20201001</creationdate><title>The Importance of Tumor Length in Needle Biopsies of the Prostate</title><author>Vollmer, Robin T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-81b59fe102b8286446520f3823235a22dd5e857465d48bc31ad2550aa9f485903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Cancer surgery</topic><topic>Care and treatment</topic><topic>Humans</topic><topic>Male</topic><topic>Measurement</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Pathology</topic><topic>Physiological aspects</topic><topic>Prognosis</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Prostate-specific antigen</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - mortality</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Tumors</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vollmer, Robin T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vollmer, Robin T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Importance of Tumor Length in Needle Biopsies of the Prostate</atitle><jtitle>American journal of clinical pathology</jtitle><addtitle>Am J Clin Pathol</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>154</volume><issue>4</issue><spage>533</spage><epage>535</epage><pages>533-535</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><abstract>Abstract
Objectives
To form a composite predictor variable that combines the effects of tumor length, serum prostate-specific antigen (PSA), and International Society of Urologic Pathologists (ISUP) grade on the observation of adverse prostatectomy pathology.
Methods
Logistic regression analysis was used to demonstrate how tumor length, serum PSA, and ISUP grade related to adverse prostatectomy results and to derive weighting factors for a composite variable, cx.
Results
The composite variable, cx, relates closely to adverse prostatectomy results as well as to observed PSA failure.
Conclusions
The composite variable cx uses preoperative information that may allow the sorting of patients into low, intermediate, and high risk for adverse outcomes after prostatectomy.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>32556114</pmid><doi>10.1093/ajcp/aqaa068</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9173 |
| ispartof | American journal of clinical pathology, 2020-10, Vol.154 (4), p.533-535 |
| issn | 0002-9173 1943-7722 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2415286939 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult Aged Biopsy Biopsy, Needle Cancer surgery Care and treatment Humans Male Measurement Middle Aged Neoplasm Grading Pathology Physiological aspects Prognosis Prostate Prostate cancer Prostate-specific antigen Prostate-Specific Antigen - blood Prostatectomy Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Tumors Urological surgery |
| title | The Importance of Tumor Length in Needle Biopsies of the Prostate |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Importance%20of%20Tumor%20Length%20in%20Needle%20Biopsies%20of%20the%20Prostate&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=Vollmer,%20Robin%20T&rft.date=2020-10-01&rft.volume=154&rft.issue=4&rft.spage=533&rft.epage=535&rft.pages=533-535&rft.issn=0002-9173&rft.eissn=1943-7722&rft_id=info:doi/10.1093/ajcp/aqaa068&rft_dat=%3Cgale_proqu%3EA645080202%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476118388&rft_id=info:pmid/32556114&rft_galeid=A645080202&rft_oup_id=10.1093/ajcp/aqaa068&rfr_iscdi=true |